Get started
Author

Marta A. B. R. Carvalho

Observed names: Marta A. Carvalho, Marta Carvalho
ORCID: 0000-0002-6323-8599
Observed ORCID: 0000-0002-6323-8599
OpenAlex ID: A5083152222
Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework
2017 · Marta Carvalho, Bruno Sepodes, et al. · Frontiers in Medicine · 65
PDF
Discovery of new heterocycles with activity against human neutrophile elastase based on a boron promoted one-pot assembly reaction
2013 · Francesco Montalbano, Pedro M. S. D. Cal, et al. · Organic & Biomolecular Chemistry · 39
Hurdles in gene therapy regulatory approval: a retrospective analysis of European Marketing Authorization Applications
2018 · Marta Carvalho, Ana Paula Martins, et al. · Drug Discovery Today · 31
PDF
Sequences in the HSP90 promoter form G-quadruplex structures with selectivity for disubstituted phenyl bis-oxazole derivatives
2012 · Stephan A. Ohnmacht, Marialuisa Micco, et al. · Bioorganic & Medicinal Chemistry Letters · 28
Patient access to gene therapy medicinal products: a comprehensive review
2020 · Marta Carvalho, Bruno Sepodes, et al. · BMJ Innovations · 22
PDF
Clinical Trials in Portugal: How Can we Improve?
2021 · Marta Carvalho, Rita Cunha de Eça, et al. · Acta Médica Portuguesa · 7
PDF
Advanced therapy medicinal products : new strategies for clinical applications of cell and gene therapy
2020 · Marta Carvalho · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
ChemInform Abstract: Discovery of New Heterocycles with Activity Against Human Neutrophile Elastase Based on a Boron Promoted One‐Pot Assembly Reaction.
2013 · Francesco Montalbano, Pedro M. S. D. Cal, et al. · ChemInform
Works count: 8
Citation count: 192
H-index: 6
I10-index: 5
Year
Topic
Type